Regulations.gov document
2025-001022 - Labonix Corp - PureWell UNWIND - CALMS DOWN NERVOUS SYSTEM WITHOUT DIRECT…
Other · FDA-2025-S-0024 · posted Oct 8, 2025
Key facts
| Document ID | FDA-2025-S-0024-0943 |
|---|---|
| Title | 2025-001022 - Labonix Corp - PureWell UNWIND - CALMS DOWN NERVOUS SYSTEM WITHOUT DIRECT SLEEP EFFECT |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2025-S-0024 |
| Posted | Oct 8, 2025 |
| Comment period opens | Oct 8, 2025 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: